Grant: Discovery Grants Program - Individual
University of Toronto
$59,000.00
Specificity of cellular signaling scaffolds
EF 2020-21
Résumé
14-3-3 proteins comprise a family of highly conserved and abundant regulatory molecules. They interact with a large number of target (client) proteins in a phosphorylation-dependent manner. By so doing, they are critical components of most eukaryotic signaling pathways. 14-3-3 clients are structurally and functionally highly diverse. They are involved in e.g. cell cycle, apoptosis, DNA damage, transcription, and cell motility. Intriguingly, the exact mode of action of 14-3-3 proteins varies depending on the client protein. They can regulate their clients' enzymatic activity, conformation, assembly into complexes, subcellular localization, or mediate aggregation. Consequently, 14-3-3s represent an unusually versatile regulatory platform for signaling in eukaryotes.
Proteomic studies have begun to unravel the client repertoire of 14-3-3 proteins. However, due to different experimental methods, cell lines, and assay sensitivity, the overlap between these studies is rather modest. Perhaps more importantly, however, standard non-quantitative approaches cannot address one of the major questions in the field: isoform specificity. Almost all organisms express multiple 14-3-3 isoforms, but their specificity is virtually identical in vitro. However, mouse studies have revealed striking isoform-specific phenotypes, suggesting that current proteomic methods are insufficiently sensitive and quantitative.
I propose to combine quantitative state-of-the-art mass spectrometry with quantitative pairwise interaction assays to comprehensively characterize the client protein repertoire of all seven human 14-3-3 isoforms in isogenic cell lines. We will uncover novel client proteins, identify isoform-specific interactions, and dissect the basis of specificity at the molecular level. These experiments will be complemented with detailed functional follow-up studies. I will take advantage of my extensive experience with chaperones, which, like 14-3-3s, are abundant molecules with thousands of transiently associating client proteins. In particular, the high-throughput interaction assay LUMIER with BACON, which I developed as a postdoctoral fellow, provides a sensitive and quantitative readout for transient 14-3-3/client interactions.
Taken together, our studies will lead to a much more comprehensive understanding of phosphorylation-dependent signaling pathways that are key mediators in development and misregulated in diverse pathologies.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2016-06318
Name nom
Taipale, Mikko
Department département
Donnelly Centre
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2016
Award amount
59000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Biologie moléculaire
Research subject en
Protein manipulation and expression
Research subject fr
Expression et recombinaison protéiques
Installment
inst:5-6
Partie
2
Nb partie
6
Application title
Specificity of cellular signaling scaffolds
Keyword
NSERC
Application summary
14-3-3 proteins comprise a family of highly conserved and abundant regulatory molecules. They interact with a large number of target (client) proteins in a phosphorylation-dependent manner. By so doing, they are critical components of most eukaryotic signaling pathways. 14-3-3 clients are structurally and functionally highly diverse. They are involved in e.g. cell cycle, apoptosis, DNA damage, transcription, and cell motility. Intriguingly, the exact mode of action of 14-3-3 proteins varies depending on the client protein. They can regulate their clients' enzymatic activity, conformation, assembly into complexes, subcellular localization, or mediate aggregation. Consequently, 14-3-3s represent an unusually versatile regulatory platform for signaling in eukaryotes.
Proteomic studies have begun to unravel the client repertoire of 14-3-3 proteins. However, due to different experimental methods, cell lines, and assay sensitivity, the overlap between these studies is rather modest. Perhaps more importantly, however, standard non-quantitative approaches cannot address one of the major questions in the field: isoform specificity. Almost all organisms express multiple 14-3-3 isoforms, but their specificity is virtually identical in vitro. However, mouse studies have revealed striking isoform-specific phenotypes, suggesting that current proteomic methods are insufficiently sensitive and quantitative.
I propose to combine quantitative state-of-the-art mass spectrometry with quantitative pairwise interaction assays to comprehensively characterize the client protein repertoire of all seven human 14-3-3 isoforms in isogenic cell lines. We will uncover novel client proteins, identify isoform-specific interactions, and dissect the basis of specificity at the molecular level. These experiments will be complemented with detailed functional follow-up studies. I will take advantage of my extensive experience with chaperones, which, like 14-3-3s, are abundant molecules with thousands of transiently associating client proteins. In particular, the high-throughput interaction assay LUMIER with BACON, which I developed as a postdoctoral fellow, provides a sensitive and quantitative readout for transient 14-3-3/client interactions.
Taken together, our studies will lead to a much more comprehensive understanding of phosphorylation-dependent signaling pathways that are key mediators in development and misregulated in diverse pathologies.